Screener
Sonoma Pharmaceuticals, Inc. SNOA Q1 2025 Annual earnings
Reported June 17, 2025 · Before market open
Revenue$3.8MMiss by $685.6K
EPS-$0.15Beat by $0.58
Revenue estimate$4.4M
EPS estimate-$0.73
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$5.3M
EPS estimate-$0.10
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Sonoma Pharmaceuticals, Inc. report Q1 2025 earnings?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported Q1 2025 earnings on June 17, 2025 before market open.
- What were Sonoma Pharmaceuticals, Inc.'s Q1 2025 revenue and EPS?
- Sonoma Pharmaceuticals, Inc. reported revenue of $3.8M and eps of $-0.15 for Q1 2025.
- Did Sonoma Pharmaceuticals, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $4.4M by $685.6K. EPS beat the consensus estimate of $-0.73 by $0.58.
- How did Sonoma Pharmaceuticals, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 9.2% from $3.4M a year earlier and eps grew 89.3% from $-1.40.
- Where can I find Sonoma Pharmaceuticals, Inc.'s Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001683168-25-004546) directly on SEC EDGAR. The filing index links above go to sec.gov.
